HSBC Holdings’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$518K Sell
977
-3,110
-76% -$1.44M ﹤0.01% 2264
2026
Q1
$1.95M Buy
4,087
+258
+7% +$132K ﹤0.01% 1542
2025
Q4
$2.16M Buy
+3,829
New +$2.17M ﹤0.01% 1533
2025
Q2
Sell
-4,364
Closed -$1.3M 3156
2025
Q1
$1.3M Buy
4,364
+2,669
+157% +$898K ﹤0.01% 1643
2024
Q4
$566K Sell
1,695
-2,805
-62% -$951K ﹤0.01% 2102
2024
Q3
$1.49M Sell
4,500
-4,362
-49% -$1.66M ﹤0.01% 1540
2024
Q2
$3.75M Sell
8,862
-3,168
-26% -$1.25M ﹤0.01% 1161
2024
Q1
$4.86M Buy
12,030
+4,227
+54% +$1.49M ﹤0.01% 1110
2023
Q4
$2.39M Buy
+7,803
New +$2.11M ﹤0.01% 1417
2022
Q2
Sell
-2,423
Closed -$398K 3366
2022
Q1
$398K Buy
+2,423
New +$400K ﹤0.01% 2578
2021
Q3
Sell
-1,766
Closed -$313K 3089
2021
Q2
$313K Buy
+1,766
New +$305K ﹤0.01% 2486
2021
Q1
Sell
-4,212
Closed -$585K 2978
2020
Q4
$585K Buy
4,212
+1,365
+48% +$172K ﹤0.01% 2079
2020
Q3
$322K Buy
+2,847
New +$329K ﹤0.01% 2209
2020
Q1
Sell
-5,210
Closed -$438K 2896
2019
Q4
$438K Sell
5,210
-8,928
-63% -$691K ﹤0.01% 2296
2019
Q3
$1.19M Buy
14,138
+6,863
+94% +$519K ﹤0.01% 1864
2019
Q2
$476K Sell
7,275
-41,967
-85% -$2.42M ﹤0.01% 2089
2019
Q1
$2.9M Buy
49,242
+32,281
+190% +$1.93M 0.01% 1340
2018
Q4
$898K Buy
+16,961
New +$931K ﹤0.01% 1845
2018
Q3
Sell
-168,675
Closed -$7.25M 2598
2018
Q2
$7.25M Buy
168,675
+149,801
+794% +$6.05M 0.01% 950
2018
Q1
$659K Sell
18,874
-29,956
-61% -$1.09M ﹤0.01% 1828
2017
Q4
$1.77M Buy
+48,830
New +$1.71M ﹤0.01% 1149

Other funds holding MEDP

HSBC Holdings's MEDP Position: Q2 2026 in Review

HSBC Holdings reduced its Medpace (MEDP) stake by 76% in Q2 2026, selling an estimated $1.44M and leaving 977 shares worth $518K. The position accounts for ﹤0.01% of the portfolio, ranked #2264.

HSBC Holdings first reported a position in MEDP in Q4 2017 and has held it in 21 quarters since. The position peaked at $7.25M in Q2 2018. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • HSBC Holdings held 977 shares of Medpace worth $518K as of Q2 2026.
  • HSBC Holdings sold 3,110 Medpace shares in Q2 2026, an estimated $1.44M.
  • Medpace made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2264 holding.
  • HSBC Holdings first reported a position in Medpace in Q4 2017 and has held it in 21 quarters since.
  • HSBC Holdings's Medpace position peaked at $7.25M in Q2 2018.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.